Braidwell Overview

  • Investor Type
  • Hedge Fund

  • Status
  • Active

  • Professionals
  • 40

Professionals

  • Investments
  • 31

  • Portfolio
  • 15

  • Exits
  • 12

Exits

Braidwell General Information

Company Description

Founded in 2021, Braidwell invests in companies that seek to push the boundaries of medicine, science, and technology to transform human health. Powered by a seasoned team, they capitalize on the combined learned experience of a close-knit group of leaders in investment research, medical science, biostatistics, commercial analysis, financial structuring, data/computer science, and portfolio engineering.

Business Details

Website
www.braidwell.com
Year Founded
2021
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Lender/Debt Provider
Venture Capital
Corporate Office
  • One Harbor Point
  • 2200 Atlantic Stree, 4th Floor
  • Stamford, CT 06902
  • United States
+1 (866)

Braidwell Investments (31)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Encoded 04-Aug-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 1
Proxima (Drug Discovery) 09-Jun-2026 Drug Discovery Generating Revenue
Nabla Bio 15-May-2026 Drug Discovery Generating Revenue
Relmada Therapeutics 09-Mar-2026 Drug Discovery Generating Revenue
Impulse Dynamics 10-Dec-2025 Therapeutic Devices Generating Revenue
GRAIL 12-Nov-2025 Biotechnology Generating Revenue
Lila Sciences 14-Sep-2025 Business/Productivity Software Generating Revenue
Crescent Biopharma 16-Jun-2025 Biotechnology Generating Revenue/Not Profitable
Jade Biosciences 28-Apr-2025 PIPE Biotechnology Generating Revenue/Not Profitable
Surrozen 26-Mar-2025 PIPE Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 31 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Braidwell Exits (12)

Company Name Exit Date Exit Type Exit Size
Crescent Biopharma 16-Jul-2026 Public Investment 2nd Offering
Jade Biosciences 03-Jun-2026
Oruka Therapeutics 28-Apr-2026
Day One Biopharmaceuticals 23-Apr-2026
Ventyx Biosciences 04-Mar-2026
Elektrofi 18-Nov-2025
Lexeo Therapeutics 16-Oct-2025
Compass Therapeutics 13-Aug-2025
Allakos 15-May-2025 Merger/Acquisition
Spyre Therapeutics 19-Nov-2024 Public Investment 2nd Offering
You’re viewing 10 of 12 exits. Get the full list »

Braidwell Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Braidwell FAQs

  • What is Braidwell?

    Founded in 2021, Braidwell invests in companies that seek to push the boundaries of medicine, science, and technology to transform human health.

  • When was Braidwell founded?

    Braidwell was founded in 2021.

  • Where is Braidwell headquartered?

    Braidwell is headquartered in Stamford, CT.

  • What is Braidwell's total asset value?

    Braidwell has around in total assets under management.

  • How many investments has Braidwell made?

    Braidwell has made 31 investments.

  • What has Braidwell invested in?

    Braidwell has made numerous investments in companies like Encoded, Proxima (Drug Discovery), and Nabla Bio within the Drug Discovery industry.

  • What has Braidwell invested in recently?

    Braidwell's latest investment was on 04-Aug-2026 in Encoded, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process